
Blood Tests Enter Colorectal Cancer Screening Guidelines
The American Cancer Society has added blood-based screening to its colorectal cancer guideline for adults 45+ at average risk who decline or have not completed visual exams or stool tests, endorsing Guardant Health's Shield blood test alongside at-home stool tests such as Cologuard Plus and ColoSense; however, blood-based tests are less sensitive for precancerous polyps and are considered a secondary option when other tests aren't completed, with colonoscopy remaining the gold standard.
